These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14675893)

  • 41. DAKOTACARE update: Let's save a Million Hearts.
    Amundson EP
    S D Med; 2012 May; 65(5):195. PubMed ID: 22679657
    [No Abstract]   [Full Text] [Related]  

  • 42. Stroke prevention.
    Weir E
    CMAJ; 2005 Aug; 173(4):363. PubMed ID: 16103506
    [No Abstract]   [Full Text] [Related]  

  • 43. [Implications of the REACH registry for neurologists].
    Roquer J
    Med Clin (Barc); 2009 Sep; 132 Suppl 2():30-3. PubMed ID: 19631836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspirin for prevention of myocardial infarction and stroke: is the right dose 81 or 160 mg/day?
    Dalen JE
    J Am Coll Cardiol; 2009 May; 53(21):2010; author reply 2010. PubMed ID: 19460618
    [No Abstract]   [Full Text] [Related]  

  • 45. Effectiveness of B-complex vitamins for prevention of cardiovascular events.
    Kripke C
    Am Fam Physician; 2010 Apr; 81(7):850. PubMed ID: 20353143
    [No Abstract]   [Full Text] [Related]  

  • 46. [Status of homocysteine reduction in prevention of cardiovascular diseases. HOPE-2 study (Heart Outcomes Prevention Evaluation)].
    Strasser RH
    Internist (Berl); 2007 Mar; 48(3):327-9. PubMed ID: 17333057
    [No Abstract]   [Full Text] [Related]  

  • 47. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
    Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimamoto K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimada K; Tanaka H; Yoshiike N;
    Hypertens Res; 2008 Mar; 31(3):469-78. PubMed ID: 18497466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin to prevent heart attack and stroke: what's the right dose?
    Dalen JE
    Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Primary and secondary prevention of myocardial infarct].
    Wilhelmsen L
    Lakartidningen; 1972 Oct; 69(41):4648-51. PubMed ID: 5072450
    [No Abstract]   [Full Text] [Related]  

  • 52. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.
    Tanne D; Haim M; Goldbourt U; Boyko V; Reshef T; Adler Y; Benderly M; Mekori YA; Behar S
    Int J Cardiol; 2006 Mar; 107(3):322-6. PubMed ID: 16503253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triggering of acute cardiovascular disease and potential preventive strategies.
    Tofler GH; Muller JE
    Circulation; 2006 Oct; 114(17):1863-72. PubMed ID: 17060396
    [No Abstract]   [Full Text] [Related]  

  • 55. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between stroke and acute myocardial infarction and its related risk factors: hypertension and diabetes.
    Bener A; Kamran S; Elouzi EB; Hamad A; Heller RF
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):24-7. PubMed ID: 16524796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical trials in the secondary prevention of myocardial infarction and stroke.
    Armitage P
    Thromb Haemost; 1980 Jun; 43(2):90-8. PubMed ID: 7455980
    [No Abstract]   [Full Text] [Related]  

  • 58. Stroke epidemic in India - time to prioritize prevention strategies.
    Dalai PM; Shenoy A
    J Assoc Physicians India; 2013 Oct; 61(10):693-5. PubMed ID: 24772723
    [No Abstract]   [Full Text] [Related]  

  • 59. [Science, health and education: a priority and a model].
    Fúster V
    Arch Cardiol Mex; 2010; 80(4):261-71. PubMed ID: 21169091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Organizational Update: World Health Organization.
    Varghese C; Onuma O; Johnson W; Brainin M; Hacke W; Norrving B
    Stroke; 2017 Dec; 48(12):e341-e342. PubMed ID: 29146876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.